Major depressive disorder with psychotic features induced by interferon-α treatment for hepatitis C in a polydrug abuser

Journal of Psychopharmacology

Volumn 19, Issue 1, 2005, Pages 102-105

  Kalyoncu, O Ayhan ^a   Tan, Devran ^a   Mirsal, Hasan ^a   Pektas, Ozkan ^a   Beyazyurek, Mansur ^a  

^a MALTEPE UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Depression; Drug abuse; Hepatitis C; Interferon

Indexed keywords

ALPHA INTERFERON; BIPERIDEN; CANNABIS; DIAMORPHINE; ILLICIT DRUG;

ADULT; AGITATION; ALCOHOL ABUSE; ANGER; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; CONSCIOUSNESS DISORDER; CYTOKINE PRODUCTION; DELIRIUM; DELUSION; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG MEGADOSE; FAMILY HISTORY; FATIGUE; FEAR; HALLUCINATION; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; INSOMNIA; IRRITABILITY; MAJOR DEPRESSION; MALE; MANIA; MENTAL INSTABILITY; MENTAL IRRITATION; PARANOIA; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR;

ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; ANTIVIRAL AGENTS; DELUSIONS; DEPRESSIVE DISORDER, MAJOR; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; SUBSTANCE-RELATED DISORDERS;

EID: 12444262184     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105048905     Document Type: Article

References (25)

1. Asnis G M, De La Garza R, Kohn S R, Reinus J F, Henderson M, Shah J (2003) IFN-induced depression: a role for NSAIDs. Psychopharmacol Bull 37: 29-50
2. Bozikas V, Petrikis P, Balla A, Karavatos A (2001) An interferon-a induced psychotic disorder in a patient with chronic hepatitis C. Eur Psychiatry 16: 136-137
3. Consensus Statements: NIH Consensus Development Program (2002) Management of Hepatitis C. National Institutes of Health, Bethesda 19: 1-14
4. Dieperink E, Willenbring M, Ho S B (2000) Neuropsychiatrie symptoms associated with hepatitis C and interferon alpha. Am J Psychiatry 157: 867-876
5. Fukunishi K, Tanaka H, Maruyama J, Takahashi H, Kitagishi H, Ueshima T, Maruyuma K, Sakata I (1998) Burns in a suicide attempt related to psychiatric effects of interferon. Bums 24: 581-583
6. Hauser P, Soler R, Reed S, Kane R, Gulati M, Khosla J, Kling M A, Valentine A D, Meyers C A (2000) Prophylactic treatment of depression induced by interferon-alpha. Psychosomatics 41: 439-441
7. Hendrik A (1994) Psychosis during interferon in eosinophilic leukemia. Clin Lab Haematol 16: 295-296
8. Hosoda S, Takimura H, Shibayama M, Kanamura H, Ikeda K, Kumada H (2000) Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurosci 54: 565-572
9. Howes O D, McKenzie K J (2000) Manic psychosis induced by long term alpha-interferon treatment for hepatitis C. Int J Psychiatr Clin Pract 4: 161-162
10. Katafuchi T, Take S, Hori T (1995) Roles of cytokines in the neural immune reactions: modulation of NMDA-responses by IFN-alpha. Neurobiology 3: 319-327
11. Lerner D M, Stoudemire A, Rosenstein D L (1999) Neuropsychiatric toxicity associated with cytokine therapies. Psychosomatics 40: 428-435
12. Malek-Ahmadi P (2001) Mood disorders associated with interferon treatment: theoretical and practical considerations. Ann Pharmacother 35: 489-495
13. McDonald E M, Mann A H, Thomas H C (1987) Interferons as mediators of psychiatric morbidity. Lancet 2: 1175-1178
14. Meyers C A, Scheibel R S, Forman A D (1991) Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41: 672-676
15. Mirsal H, Kalyoncu A O, Pektas O, Tan D, Beyazyurek M (2003) The prevalance of hepatitis B, C and HIV seropositivity among i.v. heroin users. J Depend 4: 10-14
16. Muraoka H, Sanefuji T, Keida R, Tsuji R, Abe H, Uchimura Y, Sata M, Tanikawa K, Nose I, Uchimura N, Nakazawa Y (1996) A patient with chronic hepatitis C and a history of drug abuse of analeptic drugs, who showed hallucination and delusion with interferon administration. Kurume Med J 43: 73-77
17. Musselman D L, Lawson D H, Gumnick J F, Manatunga A K, Penna S, Goodkin R S, Greiner K, Nemeroff C B, Miller A H (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344: 961-966
18. Nozaki O, Takagi C, Takaoka K, Takata T, Yoshida M (1997) Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry Clin Neurosci 51: 175-180
19. Onyike C U, Bonner J O, Lykestos C G, Treisman G J (2004) Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Am J Psychiatry 161: 429-435
20. Pariante C M, Orru M G, Baita A, Farci M G, Carpiniello B (1999) Treatment with interferon alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 354: 131-132
21. Renault P F, Hoofnagle J H (1989) Side effects of alpha interferon. Sem Liv Dis 9: 273-277
22. Renault P F, Hoofnagle J H, Park Y, Mullen K D, Peters M, Jones B, Rustgi V, Jones E (1987) Psychiatric complications of long term interferon alpha therapy. Arch Int Med 147: 1577-1580
23. Schafer M, Boetsch T, Laakmann G (2000) Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C. Addiction 95: 1101-1104
24. Tamam L, Yerdelen D, Ozpoyraz N (2003) Psychosis associated with interferon alfa therapy for chronic hepatitis B. Ann Pharmacother 37: 384-386
25. Valentine A D, Meyers C A, Kling M A, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-α therapy. Semin Oncol 25 (Suppl 1): 39-47